WS #11609
Vera Therapeutics wins FDA approval for Trutakna kidney disease therapy, a positive catalyst for VERA stock.
Biotech catalyst: Vera Therapeutics FDA approval
Vera Therapeutics wins FDA approval for Trutakna kidney disease therapy, a positive catalyst for VERA stock.